Lv4
710 积分 2022-12-16 加入
The GPR40 novel agonist SZZ15‐11 improves non‐alcoholic fatty liver disease by activating the AMPK pathway and restores metabolic homeostasis in diet‐induced obese mice
5天前
已完结
Diosgenin ameliorating non‐alcoholic fatty liver disease via Nrf2‐mediated regulation of oxidative stress and ferroptosis
5天前
已完结
Daphnetin ameliorates hepatic steatosis by suppressing peroxisome proliferator-activated receptor gamma (PPARG) in ob/ob mice
6天前
已完结
Caveolin-1 ameliorates hepatic injury in non-alcoholic fatty liver disease by inhibiting ferroptosis via the NOX4/ROS/GPX4 pathway
6天前
已完结
Therapeutic landscape of metabolic dysfunction-associated steatohepatitis (MASH)
1个月前
已完结
Natural history of metabolic dysfunction-associated steatotic liver disease
1个月前
已完结
Early liver transplantation for severe alcohol-related hepatitis not responding to medical treatment: a prospective controlled study
1个月前
已完结
Current status and future trends of the global burden of MASLD
1个月前
已完结
KLF2 mediates the suppressive effect of BDNF on diabetic intimal calcification by inhibiting HK1 induced endothelial-to-mesenchymal transition
1个月前
已完结
Induction of KLF2 by Exercise Activates eNOS to Improve Vasodilatation in Diabetic Mice
1个月前
已完结
皖公网安备34019202002308
